Use of antioxidants during chemotherapy and radiotherapy should be avoided

被引:165
作者
D'Andrea, GM [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA
关键词
D O I
10.3322/canjclin.55.5.319
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Many patients being treated for cancer use dietary supplements, particularly antioxidants, in the hope of reducing the toxicity of chemotherapy and radiotherapy. Some researchers have claimed, furthermore, that antioxidants also increase the effectiveness of cytotoxic therapy and have explicitly recommended their use. However, mechanistic considerations suggest that antioxidants might reduce the effects of conventional cytotoxic therapies. Preclinical data are currently inconclusive and a limited number of clinical studies have not found any benefit. Clinicians should advise their patients against the use of antioxidant dietary supplements during chemotherapy or radiotherapy. Such caution should be seen as the standard approach for any unproven agent that may be harmful.
引用
收藏
页码:319 / 321
页数:3
相关论文
共 28 条
[1]  
Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group, 1994, N Engl J Med, V330, P1029, DOI 10.1056/NEJM199404143301501
[2]  
Antunes LMG, 2000, PHARMACOL RES, V41, P405, DOI 10.1006/phrs.1999.0600
[3]   A randomized trial of antioxidant vitamins to prevent second primary cancers in head and neck cancer patients [J].
Bairati, I ;
Meyer, F ;
Gélinas, M ;
Fortin, A ;
Nabid, A ;
Brochet, F ;
Mercier, JP ;
Têtu, B ;
Harel, F ;
Mâsse, B ;
Vigneault, E ;
Vass, S ;
del Vecchio, P ;
Roy, J .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (07) :481-488
[4]   Antioxidant supplements for prevention of gastrointestinal cancers: a systematic review and meta-analysis [J].
Bjelakovic, G ;
Nikolova, D ;
Simonetti, RG ;
Gluud, C .
LANCET, 2004, 364 (9441) :1219-1228
[5]   Use of alternative medicine by women with early-stage breast cancer [J].
Burstein, HJ ;
Gelber, S ;
Guadagnoli, E ;
Weeks, JC .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (22) :1733-1739
[6]   SUPPLEMENTAL ASCORBATE IN SUPPORTIVE TREATMENT OF CANCER - PROLONGATION OF SURVIVAL TIMES IN TERMINAL HUMAN CANCER .1. [J].
CAMERON, E ;
PAULING, L .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1976, 73 (10) :3685-3689
[7]   Antioxidants enhance the cytotoxicity of chemotherapeutic agents in colorectal cancer: A p53-independent induction of p21(WAF1/CIP1) via C/EBP beta [J].
Chinery, R ;
Brockman, JA ;
Peeler, MO ;
Shyr, Y ;
Beauchamp, RD ;
Coffey, RJ .
NATURE MEDICINE, 1997, 3 (11) :1233-1241
[8]   The in vitro cytotoxicity of ascorbate depends on the culture medium used to perform the assay and involves hydrogen peroxide [J].
Clément, MV ;
Ramalingam, J ;
Long, LH ;
Halliwell, B .
ANTIOXIDANTS & REDOX SIGNALING, 2001, 3 (01) :157-163
[9]   FAILURE OF HIGH-DOSE VITAMIN-C (ASCORBIC-ACID) THERAPY TO BENEFIT PATIENTS WITH ADVANCED CANCER - CONTROLLED TRIAL [J].
CREAGAN, ET ;
MOERTEL, CG ;
OFALLON, JR ;
SCHUTT, AJ ;
OCONNELL, MJ ;
RUBIN, J ;
FRYTAK, S .
NEW ENGLAND JOURNAL OF MEDICINE, 1979, 301 (13) :687-690
[10]   Mechanism of vitamin C inhibition of cell death induced by oxidative stress in glutathione-depleted HL-60 cells [J].
Guaiquil, VH ;
Vera, JC ;
Golde, DW .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (44) :40955-40961